Zobrazeno 1 - 10
of 549
pro vyhledávání: '"Jean‐Michel Dogné"'
Autor:
Grégoire Wieërs, Simon Absil, Isabelle Maystadt, Charles Nicaise, Pauline Modrie, François-Xavier Sibille, Ludovic Melly, Jean-Michel Dogné
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionHow to adapt the curriculum of medicine, pharmacy, and biomedical sciences to prepare future health professionals to meet the challenge of maintaining quality care in a period of socio-ecological crisis? Addressing connections between hum
Externí odkaz:
https://doaj.org/article/bc62ac3ce2ae4e1cbab52be32dd8839f
Autor:
Jonathan Douxfils, Lucie Raskin, Marie Didembourg, Nathalie Donis, Jean-Michel Dogné, Laure Morimont, Charlotte Beaudart
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundVenous thromboembolism (VTE) poses a significant global health challenge, notably exacerbated by the use of combined oral contraceptives (COCs). Evidence mainly focuses on the type of progestogen used in COCs to establish the increased risk
Externí odkaz:
https://doaj.org/article/af8122ea22314539835eec4cb54a8c4c
Autor:
Julien Favresse, Marie Tré-Hardy, Constant Gillot, Roberto Cupaiolo, Alain Wilmet, Ingrid Beukinga, Laurent Blairon, Jean-Louis Bayart, Mélanie Closset, Loris Wauthier, Julien Cabo, Clara David, Marc Elsen, Jean-Michel Dogné, Jonathan Douxfils
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36116- (2024)
Introduction: Some studies suggest that the monovalent mRNA-1273 vaccine is more effective than BNT162b2 in producing higher levels of antibodies. However, limited data are available, and the methods used are not directly comparable. Material and met
Externí odkaz:
https://doaj.org/article/aae5601b038f4870a68ff2793b110050
Autor:
Julien Favresse, Constant Gillot, Julien Cabo, Clara David, Jean-Michel Dogné, Jonathan Douxfils
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107028- (2024)
Objectives: An increase evasion of the SARS-CoV-2 virus toward vaccination strategies and natural immunity has been rapidly described notably because of the mutations in the spike receptor binding domain and the N-terminal domain. Methods: Participan
Externí odkaz:
https://doaj.org/article/bdbfe9f255a94fd38bd029fd0847ba72
Autor:
Constant Gillot, Jean-Louis Bayart, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils, Julien Favresse
Publikováno v:
Case Reports in Infectious Diseases, Vol 2024 (2024)
AZD7442 (150 mg of tixagevimab plus 150 mg of cilgavimab) has been approved for the preexposure prophylaxis of COVID-19 and for the treatment of adults and adolescents with COVID-19 who do not require supplemental oxygen and who are at increased risk
Externí odkaz:
https://doaj.org/article/48187b9f35a94c59a805d7f0372ec0ca
Autor:
Alessandra Buoninfante, Arno Andeweg, Alexander T. Baker, Mitesh Borad, Nigel Crawford, Jean-Michel Dogné, David Garcia-Azorin, Andreas Greinacher, Rita Helfand, Anders Hviid, Stefan Kochanek, Marta López-Fauqued, Ishac Nazy, Anand Padmanabhan, Sue Pavord, Daniel Prieto-Alhambra, Huyen Tran, Ulla Wandel Liminga, Marco Cavaleri
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-6 (2022)
Safety and efficacy of vaccines against the SARS-CoV-2 coronavirus has been demonstrated in clinical trials and next by their real world use through the course of the ongoing COVID-19 pandemic. However, very rare adverse events have been detected pos
Externí odkaz:
https://doaj.org/article/65ba9e287bd445598845098cebb4daba
Autor:
Jonathan Evrard, Romain Siriez, Céline Bouvy, Julien Favresse, Halil Yildiz, Philippe Hainaut, François Mullier, Jean‐Michel Dogné, Jonathan Douxfils
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 7, Pp n/a-n/a (2022)
Abstract Introduction The activated partial thromboplastin time (aPTT) and the prothrombin time (PT) are widely available coagulation parameters which are however poor predictors of the anticoagulant effect of direct oral anticoagulants (DOACs). Some
Externí odkaz:
https://doaj.org/article/9d121dd28dea4655bd8d0228fc63adb6
Autor:
Christelle Bizimungu, Martine Sabbe, Françoise Wuillaume, Jamila Hamdani, Philippe Koch, Jean-Michel Dogné
Publikováno v:
Vaccines, Vol 11, Iss 5, p 954 (2023)
The rapid and large-scale roll-out of new COVID-19 vaccines has led to unprecedented challenges in assessing vaccine safety. In 2021, the European Medicines Agency (EMA) processed about 1.7 million safety reports related to COVID-19 vaccines in the E
Externí odkaz:
https://doaj.org/article/98aad9d32b5b43afa815dff228a87391
Autor:
Julien Favresse, Jean-Louis Bayart, François Mullier, Marc Elsen, Christine Eucher, Sandrine Van Eeckhoudt, Tatiana Roy, Gregoire Wieers, Christine Laurent, Jean-Michel Dogné, Mélanie Closset, Jonathan Douxfils
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1495-1498 (2021)
Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccina
Externí odkaz:
https://doaj.org/article/2edc9169a3224c4d8aec49ee45b97519
Autor:
Romain Siriez, Halil Yildiz, Céline Bouvy, Hélène Haguet, Vincent Maloteau, Michaël Hardy, François Mullier, Jean‐Michel Dogné, Philippe Hainaut, Jonathan Douxfils
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Introduction Edoxaban is the only anti‐Xa inhibitor metabolized in pharmacologically active moiety that could interfere with chromogenic anti‐Xa assays, especially in case of drug‐drug interactions or physiological disorders. Materials
Externí odkaz:
https://doaj.org/article/08581d03bbff47d1ae19a8fd6d047c18